💨 Abstract
US lawmakers and industry leaders are urging stricter export controls on US biopharmaceutical companies collaborating with China's military, citing concerns over China's strategic efforts to advance biotech capabilities. The proposed regulations aim to prevent US technology from being used for military and intelligence purposes by PLA medical institutions.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
Legal pedigree not just entrenched in SC. 1 in 3 HC judges related to judges, ex-judges or lawyers
PM Modi to reinforce India's role in strengthening regional cooperation: BIMSTEC Secy Gen
South Korea's Constitutional Court ousts impeached President Yoon
Tariffs place unnecessary strain on US-India ties: Congressman Krishnamoorthi
Legendary actor Manoj Kumar passes away at 87
Scale of cover up at each stage—SC's blistering critique of WBSSC in school jobs scam
Endorsing Waqf Bill, ex-PM Deve Gowda washes hands of any kind ‘of ism’, including secularism
Trump tariffs provoke world condemnation and fears of a $2,300 iPhone
Melbourne Cricket Ground to beef up security after two charged with guns at football match
Trump's team advising against call with Putin until he agrees to full ceasefire, NBC News reports
Powered by MessengerX.io